showed a trendp = 0.12
In patients with newly diagnosed T2D ( Supplementary Table 7 ), the p.Trp325Trp carriers showed a trend (p = 0.12) towards enhanced β-cell sensitivity to glucose during the OGTT ( Extended Data Fig. 3c ).
In patients with newly diagnosed T2D ( Supplementary Table 7 ), the p.Trp325Trp carriers showed a trend (p = 0.12) towards enhanced β-cell sensitivity to glucose during the OGTT ( Extended Data Fig. 3c ).